7NEWS Spotlight Investigates the Next Frontier of the Ozempic Revolution – 7NEWS Spotlight will examine the growing impact of weight-loss drugs in a special investigation this Sunday.
The special, led by Michael Usher, looks at whether medications such as Ozempic, Wegovy and Mounjaro could do more than transform the fight against obesity.
More than half a million Australians now use GLP-1 medications. Many have reported significant weight-loss results. However, researchers are also exploring whether these drugs may help quiet some of the brain’s most powerful addictive behaviours.
Beyond weight loss
The 7NEWS Spotlight Ozempic revolution investigation looks at the science behind the medications and the questions now being asked by researchers.
Scientists are examining whether GLP-1 drugs may help curb addictive disorders linked to alcohol, smoking, gambling and drugs. As a result, some experts believe the medications could open the next frontier in modern medicine.
The program also meets Australians who say their relationship with food was not the only thing that changed. Some describe unexpected effects on long-standing addictions and compulsive behaviours.
Promise and concern
While the potential is significant, the investigation also looks at the risks.
The special explores health warnings about the possible psychological impact of these medications. It also raises questions about long-term side effects and what remains unknown as the drugs continue to reshape treatment conversations.
In addition, 7NEWS Spotlight examines research into whether the medications could play a role beyond obesity, including in the fight against serious diseases such as cancer.
With interest in GLP-1 medications continuing to grow, the 7NEWS Spotlight Ozempic revolution investigation looks at both the promise and the concern behind one of the biggest health stories of recent years.
7NEWS Spotlight Investigates: The Next Frontier of the Ozempic Revolution airs Sunday, July 5 at 8.40pm on Seven and 7plus.
TV Central Seven content HERE
